混合PET/MR驱动衰减校正提升心血管PET/MR中18F-NaF与18F-FDG定量
本研究提出基于Patlak Ki图像分割骨骼的5类Ki/MR衰减校正(AC)方法,并设计两种双示踪剂方案,在兔子和16名人类志愿者中验证。结果显示,该方法较4类AC可提高骨组织和颈动脉壁的示踪剂摄取对比度与定量准确性。
要点
- 5类Ki/MR-AC通过PET Ki图像分割骨骼,弥补MR Dixon仅4类的不足。
- 在兔中,5类Ki/CT-AC与CT-AC的椎骨SUVmean平均差异小于1.2%。
- 人类中5类AC较4类AC提高颈动脉分叉壁和椎骨的TBR。
核心结论
- Ki驱动骨骼分割的5类混合PET/MR驱动AC可行,能显著提升骨组织和颈动脉壁的18F-NaF与18F-FDG对比度与定量。
研究设计与样本
- 方法学研究:提出5类Ki/MR-AC,并在兔子中验证Ki驱动骨骼分割,随后在16名人类志愿者的108个椎骨和颈动脉壁区域进行PET/MR验证。
主要发现
- 兔子中5类Ki/CT-AC与5类CT-AC的椎骨18F-NaF SUVmean平均差异小于1.2%。
- 以连续CT-AC为金标准,5类Ki/CT-AC较4类CT-AC降低SUVmean偏差:18F-NaF降低17.6%,R4:1方案降低15.4%。
- 无CAD指征人类中,5类AC较4类AC提高颈动脉分叉壁和椎骨的18F-NaF TBR分别17.7%和20%。
- R4:1人类队列中,5类AC提高颈动脉分叉壁和椎骨的18F-FDG:18F-NaF平均TBR分别12.2%和19.9%。
- R1:1无CAD指征队列中,5类AC提高颈动脉分叉TBR:18F-FDG 15.3%、18F-NaF 15.5%;椎骨TBR:18F-FDG 21.6%、18F-NaF 22.5%。
关键数值与推荐
- 5类Ki/MR-AC将Ki图像分割的骨骼作为第5类组织加入MR Dixon 4类AC图。
- R4:1方案:18F-FDG与18F-NaF按4:1比例同时给药。
- R1:1方案:给予等剂量18F-FDG后90分钟再给18F-NaF。
临床怎么用
- 在心血管PET/MR中,对18F-NaF或18F-FDG显像可采用Ki驱动骨骼分割的5类AC,以改善骨和邻近血管的定量。
- 双示踪剂方案R4:1或R1:1可在仅18F-FDG或双示踪剂数据中实现5类AC。
局限性
- 验证样本量有限:兔子及16名人类志愿者。
- 需进一步在更大临床人群中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The standard MR Dixon-based attenuation correction (AC) method in positron emission tomography/magnetic resonance (PET/MR) imaging segments only the air, lung, fat and soft-tissues (4-class), thus neglecting the highly attenuating bone tissues and affecting quantification in bones and adjacent vessels. We sought to address this limitation by utilizing the distinctively high bone uptake rate constant Ki expected from 18F-Sodium Fluoride (18F-NaF) to segment bones from PET data and support 5-class hybrid PET/MR-driven AC for 18F-NaF and 18F-Fluorodeoxyglucose (18F-FDG) PET/MR cardiovascular imaging. METHODS: We introduce 5-class Ki/MR-AC for (i) 18F-NaF studies where the bones are segmented from Patlak Ki images and added as the 5th tissue class to the MR Dixon 4-class AC map. Furthermore, we propose two alternative dual-tracer protocols to permit 5-class Ki/MR-AC for (ii) 18F-FDG-only data, with a streamlined simultaneous administration of 18F-FDG and 18F-NaF at 4:1 ratio (R4:1), or (iii) for 18F-FDG-only or both 18F-FDG and 18F-NaF dual-tracer data, by administering 18F-NaF 90 minutes after an equal 18F-FDG dosage (R1:1). The Ki-driven bone segmentation was validated against computed tomography (CT)-based segmentation in rabbits, followed by PET/MR validation on 108 vertebral bone and carotid wall regions in 16 human volunteers with and without prior indication of carotid atherosclerosis disease (CAD). RESULTS: In rabbits, we observed similar (< 1.2% mean difference) vertebral bone 18F-NaF SUVmean scores when applying 5-class AC with Ki-segmented bone (5-class Ki/CT-AC) vs CT-segmented bone (5-class CT-AC) tissue. Considering the PET data corrected with continuous CT-AC maps as gold-standard, the percentage SUVmean bias was reduced by 17.6% (18F-NaF) and 15.4% (R4:1) with 5-class Ki/CT-AC vs 4-class CT-AC. In humans without prior CAD indication, we reported 17.7% and 20% higher 18F-NaF target-to-background ratio (TBR) at carotid bifurcations wall and vertebral bones, respectively, with 5- vs 4-class AC. In the R4:1 human cohort, the mean 18F-FDG:18F-NaF TBR increased by 12.2% at carotid bifurcations wall and 19.9% at vertebral bones. For the R1:1 cohort of subjects without CAD indication, mean TBR increased by 15.3% (18F-FDG) and 15.5% (18F-NaF) at carotid bifurcations and 21.6% (18F-FDG) and 22.5% (18F-NaF) at vertebral bones. Similar TBR enhancements were observed when applying the proposed AC method to human subjects with prior CAD indication. CONCLUSIONS: Ki-driven bone segmentation and 5-class hybrid PET/MR-driven AC is feasible and can significantly enhance 18F-NaF and 18F-FDG contrast and quantification in bone tissues and carotid walls.
引用
- Karakatsanis NA, Abgral R, Trivieri MG, et al. Hybrid PET- and MR-driven attenuation correction for enhanced 18F-NaF and 18F-FDG quantification in cardiovascular PET/MR imaging. J Nucl Cardiol. 2019. PMID: 31667675. doi:10.1007/s12350-019-01928-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。